Ovid Therapeutics Inc. - OVID

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G ADAR1 Capital Management, LLC 6.9% 9,284,166 View
Feb 17, 2026 SCHEDULE 13G ADAR1 Capital Management GP, LLC 6.9% 9,284,166 View
Feb 17, 2026 SCHEDULE 13G Daniel Schneeberger 6.9% 9,284,166 View
Jan 29, 2026 SCHEDULE 13G/A Affinity Asset Advisors, LLC 9.0% 12,149,166 View
Jan 29, 2026 SCHEDULE 13G/A Michael Cho 9.0% 12,149,166 View
Jan 05, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 5.1% 6,727,209 View
Jan 05, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 5.1% 6,727,209 View
Jan 05, 2026 SCHEDULE 13G Steven A. Cohen 5.1% 6,727,209 View
Dec 18, 2025 SCHEDULE 13G RA Capital Management, L.P. 9.9% 13,259,735 View
Dec 18, 2025 SCHEDULE 13G Peter Kolchinsky 9.9% 13,259,735 View
Dec 18, 2025 SCHEDULE 13G Rajeev Shah 9.9% 13,259,735 View
Dec 18, 2025 SCHEDULE 13G RA Capital Healthcare Fund, L.P. 9.9% 13,259,735 View
Dec 18, 2025 SCHEDULE 13G Affinity Asset Advisors, LLC 9.0% 12,149,166 View
Dec 18, 2025 SCHEDULE 13G Affinity Healthcare Fund, LP 9.0% 12,149,166 View
Dec 08, 2025 SCHEDULE 13G JANUS HENDERSON GROUP PLC 9.99% 7,114,114 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.